Summary
According to APO Research, The global Pets Anti-infective Drugs market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Pets Anti-infective Drugs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Pets Anti-infective Drugs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Pets Anti-infective Drugs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Pets Anti-infective Drugs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Pets Anti-infective Drugs include Zoetis, Merck, Elanco, Virbac, Dechra Veterinary Products, Ceva Santé Animale, Vetoquinol, Nanjing Jindun Animal and Wuhan Chopperlvya, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Pets Anti-infective Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Pets Anti-infective Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Pets Anti-infective Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pets Anti-infective Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Pets Anti-infective Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Pets Anti-infective Drugs sales, projected growth trends, production technology, application and end-user industry.
Pets Anti-infective Drugs segment by Company
Zoetis
Merck
Elanco
Virbac
Dechra Veterinary Products
Ceva Santé Animale
Vetoquinol
Nanjing Jindun Animal
Wuhan Chopperlvya
Bimeda Animal Health
Ouro Fino Saude
Norbrook
Pets Anti-infective Drugs segment by Administration Method
External Use
Internal Use
Injection
Pets Anti-infective Drugs segment by Application
Dog
Cat
Others
Pets Anti-infective Drugs segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pets Anti-infective Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pets Anti-infective Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pets Anti-infective Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Pets Anti-infective Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Pets Anti-infective Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pets Anti-infective Drugs sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 Pets Anti-infective Drugs Market by Administration Method
1.2.1 Global Pets Anti-infective Drugs Market Size by Administration Method, 2019 VS 2023 VS 2030
1.2.2 External Use
1.2.3 Internal Use
1.2.4 Injection
1.3 Pets Anti-infective Drugs Market by Application
1.3.1 Global Pets Anti-infective Drugs Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Dog
1.3.3 Cat
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Pets Anti-infective Drugs Market Dynamics
2.1 Pets Anti-infective Drugs Industry Trends
2.2 Pets Anti-infective Drugs Industry Drivers
2.3 Pets Anti-infective Drugs Industry Opportunities and Challenges
2.4 Pets Anti-infective Drugs Industry Restraints
3 Global Market Growth Prospects
3.1 Global Pets Anti-infective Drugs Revenue Estimates and Forecasts (2019-2030)
3.2 Global Pets Anti-infective Drugs Revenue by Region
3.2.1 Global Pets Anti-infective Drugs Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Pets Anti-infective Drugs Revenue by Region (2019-2024)
3.2.3 Global Pets Anti-infective Drugs Revenue by Region (2025-2030)
3.2.4 Global Pets Anti-infective Drugs Revenue Market Share by Region (2019-2030)
3.3 Global Pets Anti-infective Drugs Sales Estimates and Forecasts 2019-2030
3.4 Global Pets Anti-infective Drugs Sales by Region
3.4.1 Global Pets Anti-infective Drugs Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Pets Anti-infective Drugs Sales by Region (2019-2024)
3.4.3 Global Pets Anti-infective Drugs Sales by Region (2025-2030)
3.4.4 Global Pets Anti-infective Drugs Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 Market Competitive Landscape by Manufacturers
4.1 Global Pets Anti-infective Drugs Revenue by Manufacturers
4.1.1 Global Pets Anti-infective Drugs Revenue by Manufacturers (2019-2024)
4.1.2 Global Pets Anti-infective Drugs Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Pets Anti-infective Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Pets Anti-infective Drugs Sales by Manufacturers
4.2.1 Global Pets Anti-infective Drugs Sales by Manufacturers (2019-2024)
4.2.2 Global Pets Anti-infective Drugs Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Pets Anti-infective Drugs Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Pets Anti-infective Drugs Sales Price by Manufacturers (2019-2024)
4.4 Global Pets Anti-infective Drugs Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Pets Anti-infective Drugs Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Pets Anti-infective Drugs Manufacturers, Product Type & Application
4.7 Global Pets Anti-infective Drugs Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Pets Anti-infective Drugs Market CR5 and HHI
4.8.2 2023 Pets Anti-infective Drugs Tier 1, Tier 2, and Tier 3
5 Pets Anti-infective Drugs Market by Type
5.1 Global Pets Anti-infective Drugs Revenue by Type
5.1.1 Global Pets Anti-infective Drugs Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Pets Anti-infective Drugs Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Pets Anti-infective Drugs Revenue Market Share by Type (2019-2030)
5.2 Global Pets Anti-infective Drugs Sales by Type
5.2.1 Global Pets Anti-infective Drugs Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Pets Anti-infective Drugs Sales by Type (2019-2030) & (K Units)
5.2.3 Global Pets Anti-infective Drugs Sales Market Share by Type (2019-2030)
5.3 Global Pets Anti-infective Drugs Price by Type
6 Pets Anti-infective Drugs Market by Application
6.1 Global Pets Anti-infective Drugs Revenue by Application
6.1.1 Global Pets Anti-infective Drugs Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Pets Anti-infective Drugs Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Pets Anti-infective Drugs Revenue Market Share by Application (2019-2030)
6.2 Global Pets Anti-infective Drugs Sales by Application
6.2.1 Global Pets Anti-infective Drugs Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Pets Anti-infective Drugs Sales by Application (2019-2030) & (K Units)
6.2.3 Global Pets Anti-infective Drugs Sales Market Share by Application (2019-2030)
6.3 Global Pets Anti-infective Drugs Price by Application
7 Company Profiles
7.1 Zoetis
7.1.1 Zoetis Comapny Information
7.1.2 Zoetis Business Overview
7.1.3 Zoetis Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Zoetis Pets Anti-infective Drugs Product Portfolio
7.1.5 Zoetis Recent Developments
7.2 Merck
7.2.1 Merck Comapny Information
7.2.2 Merck Business Overview
7.2.3 Merck Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Merck Pets Anti-infective Drugs Product Portfolio
7.2.5 Merck Recent Developments
7.3 Elanco
7.3.1 Elanco Comapny Information
7.3.2 Elanco Business Overview
7.3.3 Elanco Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Elanco Pets Anti-infective Drugs Product Portfolio
7.3.5 Elanco Recent Developments
7.4 Virbac
7.4.1 Virbac Comapny Information
7.4.2 Virbac Business Overview
7.4.3 Virbac Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Virbac Pets Anti-infective Drugs Product Portfolio
7.4.5 Virbac Recent Developments
7.5 Dechra Veterinary Products
7.5.1 Dechra Veterinary Products Comapny Information
7.5.2 Dechra Veterinary Products Business Overview
7.5.3 Dechra Veterinary Products Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Dechra Veterinary Products Pets Anti-infective Drugs Product Portfolio
7.5.5 Dechra Veterinary Products Recent Developments
7.6 Ceva Santé Animale
7.6.1 Ceva Santé Animale Comapny Information
7.6.2 Ceva Santé Animale Business Overview
7.6.3 Ceva Santé Animale Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Ceva Santé Animale Pets Anti-infective Drugs Product Portfolio
7.6.5 Ceva Santé Animale Recent Developments
7.7 Vetoquinol
7.7.1 Vetoquinol Comapny Information
7.7.2 Vetoquinol Business Overview
7.7.3 Vetoquinol Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Vetoquinol Pets Anti-infective Drugs Product Portfolio
7.7.5 Vetoquinol Recent Developments
7.8 Nanjing Jindun Animal
7.8.1 Nanjing Jindun Animal Comapny Information
7.8.2 Nanjing Jindun Animal Business Overview
7.8.3 Nanjing Jindun Animal Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 Nanjing Jindun Animal Pets Anti-infective Drugs Product Portfolio
7.8.5 Nanjing Jindun Animal Recent Developments
7.9 Wuhan Chopperlvya
7.9.1 Wuhan Chopperlvya Comapny Information
7.9.2 Wuhan Chopperlvya Business Overview
7.9.3 Wuhan Chopperlvya Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 Wuhan Chopperlvya Pets Anti-infective Drugs Product Portfolio
7.9.5 Wuhan Chopperlvya Recent Developments
7.10 Bimeda Animal Health
7.10.1 Bimeda Animal Health Comapny Information
7.10.2 Bimeda Animal Health Business Overview
7.10.3 Bimeda Animal Health Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 Bimeda Animal Health Pets Anti-infective Drugs Product Portfolio
7.10.5 Bimeda Animal Health Recent Developments
7.11 Ouro Fino Saude
7.11.1 Ouro Fino Saude Comapny Information
7.11.2 Ouro Fino Saude Business Overview
7.11.3 Ouro Fino Saude Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
7.11.4 Ouro Fino Saude Pets Anti-infective Drugs Product Portfolio
7.11.5 Ouro Fino Saude Recent Developments
7.12 Norbrook
7.12.1 Norbrook Comapny Information
7.12.2 Norbrook Business Overview
7.12.3 Norbrook Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
7.12.4 Norbrook Pets Anti-infective Drugs Product Portfolio
7.12.5 Norbrook Recent Developments
8 North America
8.1 North America Pets Anti-infective Drugs Market Size by Administration Method
8.1.1 North America Pets Anti-infective Drugs Revenue by Administration Method (2019-2030)
8.1.2 North America Pets Anti-infective Drugs Sales by Administration Method (2019-2030)
8.1.3 North America Pets Anti-infective Drugs Price by Administration Method (2019-2030)
8.2 North America Pets Anti-infective Drugs Market Size by Application
8.2.1 North America Pets Anti-infective Drugs Revenue by Application (2019-2030)
8.2.2 North America Pets Anti-infective Drugs Sales by Application (2019-2030)
8.2.3 North America Pets Anti-infective Drugs Price by Application (2019-2030)
8.3 North America Pets Anti-infective Drugs Market Size by Country
8.3.1 North America Pets Anti-infective Drugs Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Pets Anti-infective Drugs Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Pets Anti-infective Drugs Price by Country (2019-2030)
8.3.4 United States
8.3.5 Canada
9 Europe
9.1 Europe Pets Anti-infective Drugs Market Size by Administration Method
9.1.1 Europe Pets Anti-infective Drugs Revenue by Administration Method (2019-2030)
9.1.2 Europe Pets Anti-infective Drugs Sales by Administration Method (2019-2030)
9.1.3 Europe Pets Anti-infective Drugs Price by Administration Method (2019-2030)
9.2 Europe Pets Anti-infective Drugs Market Size by Application
9.2.1 Europe Pets Anti-infective Drugs Revenue by Application (2019-2030)
9.2.2 Europe Pets Anti-infective Drugs Sales by Application (2019-2030)
9.2.3 Europe Pets Anti-infective Drugs Price by Application (2019-2030)
9.3 Europe Pets Anti-infective Drugs Market Size by Country
9.3.1 Europe Pets Anti-infective Drugs Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Pets Anti-infective Drugs Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Pets Anti-infective Drugs Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 China
10.1 China Pets Anti-infective Drugs Market Size by Administration Method
10.1.1 China Pets Anti-infective Drugs Revenue by Administration Method (2019-2030)
10.1.2 China Pets Anti-infective Drugs Sales by Administration Method (2019-2030)
10.1.3 China Pets Anti-infective Drugs Price by Administration Method (2019-2030)
10.2 China Pets Anti-infective Drugs Market Size by Application
10.2.1 China Pets Anti-infective Drugs Revenue by Application (2019-2030)
10.2.2 China Pets Anti-infective Drugs Sales by Application (2019-2030)
10.2.3 China Pets Anti-infective Drugs Price by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Pets Anti-infective Drugs Market Size by Administration Method
11.1.1 Asia Pets Anti-infective Drugs Revenue by Administration Method (2019-2030)
11.1.2 Asia Pets Anti-infective Drugs Sales by Administration Method (2019-2030)
11.1.3 Asia Pets Anti-infective Drugs Price by Administration Method (2019-2030)
11.2 Asia Pets Anti-infective Drugs Market Size by Application
11.2.1 Asia Pets Anti-infective Drugs Revenue by Application (2019-2030)
11.2.2 Asia Pets Anti-infective Drugs Sales by Application (2019-2030)
11.2.3 Asia Pets Anti-infective Drugs Price by Application (2019-2030)
11.3 Asia Pets Anti-infective Drugs Market Size by Country
11.3.1 Asia Pets Anti-infective Drugs Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Pets Anti-infective Drugs Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Pets Anti-infective Drugs Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 Middle East, Africa and Latin America
12.1 MEALA Pets Anti-infective Drugs Market Size by Administration Method
12.1.1 MEALA Pets Anti-infective Drugs Revenue by Administration Method (2019-2030)
12.1.2 MEALA Pets Anti-infective Drugs Sales by Administration Method (2019-2030)
12.1.3 MEALA Pets Anti-infective Drugs Price by Administration Method (2019-2030)
12.2 MEALA Pets Anti-infective Drugs Market Size by Application
12.2.1 MEALA Pets Anti-infective Drugs Revenue by Application (2019-2030)
12.2.2 MEALA Pets Anti-infective Drugs Sales by Application (2019-2030)
12.2.3 MEALA Pets Anti-infective Drugs Price by Application (2019-2030)
12.3 MEALA Pets Anti-infective Drugs Market Size by Country
12.3.1 MEALA Pets Anti-infective Drugs Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Pets Anti-infective Drugs Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Pets Anti-infective Drugs Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 Value Chain and Sales Channels Analysis
13.1 Pets Anti-infective Drugs Value Chain Analysis
13.1.1 Pets Anti-infective Drugs Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Pets Anti-infective Drugs Production Mode & Process
13.2 Pets Anti-infective Drugs Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Pets Anti-infective Drugs Distributors
13.2.3 Pets Anti-infective Drugs Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
List of Tables
Table 1. Global Pets Anti-infective Drugs Market Size Growth Rate by Administration Method (US$ Million), 2019 VS 2023 VS 2030
Table 2. External Use Major Manufacturers
Table 3. Internal Use Major Manufacturers
Table 4. Injection Major Manufacturers
Table 5. Global Pets Anti-infective Drugs Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 6. Dog Major Manufacturers
Table 7. Cat Major Manufacturers
Table 8. Others Major Manufacturers
Table 9. Pets Anti-infective Drugs Industry Trends
Table 10. Pets Anti-infective Drugs Industry Drivers
Table 11. Pets Anti-infective Drugs Industry Opportunities and Challenges
Table 12. Pets Anti-infective Drugs Industry Restraints
Table 13. Global Pets Anti-infective Drugs Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Pets Anti-infective Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 15. Global Pets Anti-infective Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 16. Global Pets Anti-infective Drugs Revenue Market Share by Region (2019-2024)
Table 17. Global Pets Anti-infective Drugs Revenue Market Share by Region (2025-2030)
Table 18. Global Pets Anti-infective Drugs Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)
Table 19. Global Pets Anti-infective Drugs Sales by Region (2019-2024) & (K Units)
Table 20. Global Pets Anti-infective Drugs Sales by Region (2025-2030) & (K Units)
Table 21. Global Pets Anti-infective Drugs Sales Market Share by Region (2019-2024)
Table 22. Global Pets Anti-infective Drugs Sales Market Share by Region (2025-2030)
Table 23. Global Pets Anti-infective Drugs Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 24. Global Pets Anti-infective Drugs Revenue Market Share by Manufacturers (2019-2024)
Table 25. Global Pets Anti-infective Drugs Sales by Manufacturers (US$ Million) & (2019-2024)
Table 26. Global Pets Anti-infective Drugs Sales Market Share by Manufacturers (2019-2024)
Table 27. Global Pets Anti-infective Drugs Sales Price (US$/Unit) of Manufacturers (2019-2024)
Table 28. Global Pets Anti-infective Drugs Key Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 29. Global Pets Anti-infective Drugs Key Manufacturers Manufacturing Sites & Headquarters
Table 30. Global Pets Anti-infective Drugs Manufacturers, Product Type & Application
Table 31. Global Pets Anti-infective Drugs Manufacturers Commercialization Time
Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Pets Anti-infective Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 34. Global Pets Anti-infective Drugs Revenue by Administration Method 2019 VS 2023 VS 2030 (US$ Million)
Table 35. Global Pets Anti-infective Drugs Revenue by Administration Method (2019-2024) & (US$ Million)
Table 36. Global Pets Anti-infective Drugs Revenue by Administration Method (2025-2030) & (US$ Million)
Table 37. Global Pets Anti-infective Drugs Revenue Market Share by Administration Method (2019-2024)
Table 38. Global Pets Anti-infective Drugs Revenue Market Share by Administration Method (2025-2030)
Table 39. Global Pets Anti-infective Drugs Sales by Administration Method 2019 VS 2023 VS 2030 (K Units)
Table 40. Global Pets Anti-infective Drugs Sales by Administration Method (2019-2024) & (K Units)
Table 41. Global Pets Anti-infective Drugs Sales by Administration Method (2025-2030) & (K Units)
Table 42. Global Pets Anti-infective Drugs Sales Market Share by Administration Method (2019-2024)
Table 43. Global Pets Anti-infective Drugs Sales Market Share by Administration Method (2025-2030)
Table 44. Global Pets Anti-infective Drugs Price by Administration Method (2019-2024) & (US$/Unit)
Table 45. Global Pets Anti-infective Drugs Price by Administration Method (2025-2030) & (US$/Unit)
Table 46. Global Pets Anti-infective Drugs Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 47. Global Pets Anti-infective Drugs Revenue by Application (2019-2024) & (US$ Million)
Table 48. Global Pets Anti-infective Drugs Revenue by Application (2025-2030) & (US$ Million)
Table 49. Global Pets Anti-infective Drugs Revenue Market Share by Application (2019-2024)
Table 50. Global Pets Anti-infective Drugs Revenue Market Share by Application (2025-2030)
Table 51. Global Pets Anti-infective Drugs Sales by Application 2019 VS 2023 VS 2030 (K Units)
Table 52. Global Pets Anti-infective Drugs Sales by Application (2019-2024) & (K Units)
Table 53. Global Pets Anti-infective Drugs Sales by Application (2025-2030) & (K Units)
Table 54. Global Pets Anti-infective Drugs Sales Market Share by Application (2019-2024)
Table 55. Global Pets Anti-infective Drugs Sales Market Share by Application (2025-2030)
Table 56. Global Pets Anti-infective Drugs Price by Application (2019-2024) & (US$/Unit)
Table 57. Global Pets Anti-infective Drugs Price by Application (2025-2030) & (US$/Unit)
Table 58. Zoetis Company Information
Table 59. Zoetis Business Overview
Table 60. Zoetis Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 61. Zoetis Pets Anti-infective Drugs Product Portfolio
Table 62. Zoetis Recent Development
Table 63. Merck Company Information
Table 64. Merck Business Overview
Table 65. Merck Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 66. Merck Pets Anti-infective Drugs Product Portfolio
Table 67. Merck Recent Development
Table 68. Elanco Company Information
Table 69. Elanco Business Overview
Table 70. Elanco Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 71. Elanco Pets Anti-infective Drugs Product Portfolio
Table 72. Elanco Recent Development
Table 73. Virbac Company Information
Table 74. Virbac Business Overview
Table 75. Virbac Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 76. Virbac Pets Anti-infective Drugs Product Portfolio
Table 77. Virbac Recent Development
Table 78. Dechra Veterinary Products Company Information
Table 79. Dechra Veterinary Products Business Overview
Table 80. Dechra Veterinary Products Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. Dechra Veterinary Products Pets Anti-infective Drugs Product Portfolio
Table 82. Dechra Veterinary Products Recent Development
Table 83. Ceva Santé Animale Company Information
Table 84. Ceva Santé Animale Business Overview
Table 85. Ceva Santé Animale Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. Ceva Santé Animale Pets Anti-infective Drugs Product Portfolio
Table 87. Ceva Santé Animale Recent Development
Table 88. Vetoquinol Company Information
Table 89. Vetoquinol Business Overview
Table 90. Vetoquinol Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. Vetoquinol Pets Anti-infective Drugs Product Portfolio
Table 92. Vetoquinol Recent Development
Table 93. Nanjing Jindun Animal Company Information
Table 94. Nanjing Jindun Animal Business Overview
Table 95. Nanjing Jindun Animal Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. Nanjing Jindun Animal Pets Anti-infective Drugs Product Portfolio
Table 97. Nanjing Jindun Animal Recent Development
Table 98. Wuhan Chopperlvya Company Information
Table 99. Wuhan Chopperlvya Business Overview
Table 100. Wuhan Chopperlvya Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. Wuhan Chopperlvya Pets Anti-infective Drugs Product Portfolio
Table 102. Wuhan Chopperlvya Recent Development
Table 103. Bimeda Animal Health Company Information
Table 104. Bimeda Animal Health Business Overview
Table 105. Bimeda Animal Health Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. Bimeda Animal Health Pets Anti-infective Drugs Product Portfolio
Table 107. Bimeda Animal Health Recent Development
Table 108. Ouro Fino Saude Company Information
Table 109. Ouro Fino Saude Business Overview
Table 110. Ouro Fino Saude Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 111. Ouro Fino Saude Pets Anti-infective Drugs Product Portfolio
Table 112. Ouro Fino Saude Recent Development
Table 113. Norbrook Company Information
Table 114. Norbrook Business Overview
Table 115. Norbrook Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 116. Norbrook Pets Anti-infective Drugs Product Portfolio
Table 117. Norbrook Recent Development
Table 118. North America Pets Anti-infective Drugs Revenue by Administration Method (2019-2024) & (US$ Million)
Table 119. North America Pets Anti-infective Drugs Revenue by Administration Method (2025-2030) & (US$ Million)
Table 120. North America Pets Anti-infective Drugs Sales by Administration Method (2019-2024) & (K Units)
Table 121. North America Pets Anti-infective Drugs Sales by Administration Method (2025-2030) & (K Units)
Table 122. North America Pets Anti-infective Drugs Sales Price by Administration Method (2019-2024) & (US$/Unit)
Table 123. North America Pets Anti-infective Drugs Sales Price by Administration Method (2025-2030) & (US$/Unit)
Table 124. North America Pets Anti-infective Drugs Revenue by Application (2019-2024) & (US$ Million)
Table 125. North America Pets Anti-infective Drugs Revenue by Application (2025-2030) & (US$ Million)
Table 126. North America Pets Anti-infective Drugs Sales by Application (2019-2024) & (K Units)
Table 127. North America Pets Anti-infective Drugs Sales by Application (2025-2030) & (K Units)
Table 128. North America Pets Anti-infective Drugs Sales Price by Application (2019-2024) & (US$/Unit)
Table 129. North America Pets Anti-infective Drugs Sales Price by Application (2025-2030) & (US$/Unit)
Table 130. North America Pets Anti-infective Drugs Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 131. North America Pets Anti-infective Drugs Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 132. North America Pets Anti-infective Drugs Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 133. North America Pets Anti-infective Drugs Sales by Country (2019 VS 2023 VS 2030) & (K Units)
Table 134. North America Pets Anti-infective Drugs Sales by Country (2019-2024) & (K Units)
Table 135. North America Pets Anti-infective Drugs Sales by Country (2025-2030) & (K Units)
Table 136. North America Pets Anti-infective Drugs Sales Price by Country (2019-2024) & (US$/Unit)
Table 137. North America Pets Anti-infective Drugs Sales Price by Country (2025-2030) & (US$/Unit)
Table 138. US Pets Anti-infective Drugs Revenue (2019-2030) & (US$ Million)
Table 139. Canada Pets Anti-infective Drugs Revenue (2019-2030) & (US$ Million)
Table 140. Europe Pets Anti-infective Drugs Revenue by Administration Method (2019-2024) & (US$ Million)
Table 141. Europe Pets Anti-infective Drugs Revenue by Administration Method (2025-2030) & (US$ Million)
Table 142. Europe Pets Anti-infective Drugs Sales by Administration Method (2019-2024) & (K Units)
Table 143. Europe Pets Anti-infective Drugs Sales by Administration Method (2025-2030) & (K Units)
Table 144. Europe Pets Anti-infective Drugs Sales Price by Administration Method (2019-2024) & (US$/Unit)
Table 145. Europe Pets Anti-infective Drugs Sales Price by Administration Method (2025-2030) & (US$/Unit)
Table 146. Europe Pets Anti-infective Drugs Revenue by Application (2019-2024) & (US$ Million)
Table 147. Europe Pets Anti-infective Drugs Revenue by Application (2025-2030) & (US$ Million)
Table 148. Europe Pets Anti-infective Drugs Sales by Application (2019-2024) & (K Units)
Table 149. Europe Pets Anti-infective Drugs Sales by Application (2025-2030) & (K Units)
Table 150. Europe Pets Anti-infective Drugs Sales Price by Application (2019-2024) & (US$/Unit)
Table 151. Europe Pets Anti-infective Drugs Sales Price by Application (2025-2030) & (US$/Unit)
Table 152. Europe Pets Anti-infective Drugs Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 153. Europe Pets Anti-infective Drugs Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 154. Europe Pets Anti-infective Drugs Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 155. Europe Pets Anti-infective Drugs Sales by Country (2019 VS 2023 VS 2030) & (K Units)
Table 156. Europe Pets Anti-infective Drugs Sales by Country (2019-2024) & (K Units)
Table 157. Europe Pets Anti-infective Drugs Sales by Country (2025-2030) & (K Units)
Table 158. Europe Pets Anti-infective Drugs Sales Price by Country (2019-2024) & (US$/Unit)
Table 159. Europe Pets Anti-infective Drugs Sales Price by Country (2025-2030) & (US$/Unit)
Table 160. Germany Pets Anti-infective Drugs Revenue (2019-2030) & (US$ Million)
Table 161. France Pets Anti-infective Drugs Revenue (2019-2030) & (US$ Million)
Table 162. Pets Anti-infective Drugs Revenue (2019-2030) & (US$ Million)
Table 163. Pets Anti-infective Drugs Revenue (2019-2030) & (US$ Million)
Table 164. Pets Anti-infective Drugs Revenue (2019-2030) & (US$ Million)
Table 165. China Pets Anti-infective Drugs Revenue by Administration Method (2019-2024) & (US$ Million)
Table 166. China Pets Anti-infective Drugs Revenue by Administration Method (2025-2030) & (US$ Million)
Table 167. China Pets Anti-infective Drugs Sales by Administration Method (2019-2024) & (K Units)
Table 168. China Pets Anti-infective Drugs Sales by Administration Method (2025-2030) & (K Units)
Table 169. China Pets Anti-infective Drugs Sales Price by Administration Method (2019-2024) & (US$/Unit)
Table 170. China Pets Anti-infective Drugs Sales Price by Administration Method (2025-2030) & (US$/Unit)
Table 171. China Pets Anti-infective Drugs Revenue by Application (2019-2024) & (US$ Million)
Table 172. China Pets Anti-infective Drugs Revenue by Application (2025-2030) & (US$ Million)
Table 173. China Pets Anti-infective Drugs Sales by Application (2019-2024) & (K Units)
Table 174. China Pets Anti-infective Drugs Sales by Application (2025-2030) & (K Units)
Table 175. China Pets Anti-infective Drugs Sales Price by Application (2019-2024) & (US$/Unit)
Table 176. China Pets Anti-infective Drugs Sales Price by Application (2025-2030) & (US$/Unit)
Table 177. Asia Pets Anti-infective Drugs Revenue by Administration Method (2019-2024) & (US$ Million)
Table 178. Asia Pets Anti-infective Drugs Revenue by Administration Method (2025-2030) & (US$ Million)
Table 179. Asia Pets Anti-infective Drugs Sales by Administration Method (2019-2024) & (K Units)
Table 180. Asia Pets Anti-infective Drugs Sales by Administration Method (2025-2030) & (K Units)
Table 181. Asia Pets Anti-infective Drugs Sales Price by Administration Method (2019-2024) & (US$/Unit)
Table 182. Asia Pets Anti-infective Drugs Sales Price by Administration Method (2025-2030) & (US$/Unit)
Table 183. Asia Pets Anti-infective Drugs Revenue by Application (2019-2024) & (US$ Million)
Table 184. Asia Pets Anti-infective Drugs Revenue by Application (2025-2030) & (US$ Million)
Table 185. Asia Pets Anti-infective Drugs Sales by Application (2019-2024) & (K Units)
Table 186. Asia Pets Anti-infective Drugs Sales by Application (2025-2030) & (K Units)
Table 187. Asia Pets Anti-infective Drugs Sales Price by Application (2019-2024) & (US$/Unit)
Table 188. Asia Pets Anti-infective Drugs Sales Price by Application (2025-2030) & (US$/Unit)
Table 189. Asia Pets Anti-infective Drugs Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 190. Asia Pets Anti-infective Drugs Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 191. Asia Pets Anti-infective Drugs Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 192. Asia Pets Anti-infective Drugs Sales by Country (2019 VS 2023 VS 2030) & (K Units)
Table 193. Asia Pets Anti-infective Drugs Sales by Country (2019-2024) & (K Units)
Table 194. Asia Pets Anti-infective Drugs Sales by Country (2025-2030) & (K Units)
Table 195. Asia Pets Anti-infective Drugs Sales Price by Country (2019-2024) & (US$/Unit)
Table 196. Asia Pets Anti-infective Drugs Sales Price by Country (2025-2030) & (US$/Unit)
Table 197. Japan Pets Anti-infective Drugs Revenue (2019-2030) & (US$ Million)
Table 198. South Korea Pets Anti-infective Drugs Revenue (2019-2030) & (US$ Million)
Table 199. Pets Anti-infective Drugs Revenue (2019-2030) & (US$ Million)
Table 200. Pets Anti-infective Drugs Revenue (2019-2030) & (US$ Million)
Table 201. Pets Anti-infective Drugs Revenue (2019-2030) & (US$ Million)
Table 202. Pets Anti-infective Drugs Revenue (2019-2030) & (US$ Million)
Table 203. Pets Anti-infective Drugs Revenue (2019-2030) & (US$ Million)
Table 204. Pets Anti-infective Drugs Revenue (2019-2030) & (US$ Million)
Table 205. MEALA Pets Anti-infective Drugs Revenue by Administration Method (2019-2024) & (US$ Million)
Table 206. MEALA Pets Anti-infective Drugs Revenue by Administration Method (2025-2030) & (US$ Million)
Table 207. MEALA Pets Anti-infective Drugs Sales by Administration Method (2019-2024) & (K Units)
Table 208. MEALA Pets Anti-infective Drugs Sales by Administration Method (2025-2030) & (K Units)
Table 209. MEALA Pets Anti-infective Drugs Sales Price by Administration Method (2019-2024) & (US$/Unit)
Table 210. MEALA Pets Anti-infective Drugs Sales Price by Administration Method (2025-2030) & (US$/Unit)
Table 211. MEALA Pets Anti-infective Drugs Revenue by Application (2019-2024) & (US$ Million)
Table 212. MEALA Pets Anti-infective Drugs Revenue by Application (2025-2030) & (US$ Million)
Table 213. MEALA Pets Anti-infective Drugs Sales by Application (2019-2024) & (K Units)
Table 214. MEALA Pets Anti-infective Drugs Sales by Application (2025-2030) & (K Units)
Table 215. MEALA Pets Anti-infective Drugs Sales Price by Application (2019-2024) & (US$/Unit)
Table 216. MEALA Pets Anti-infective Drugs Sales Price by Application (2025-2030) & (US$/Unit)
Table 217. MEALA Pets Anti-infective Drugs Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 218. MEALA Pets Anti-infective Drugs Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 219. MEALA Pets Anti-infective Drugs Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 220. MEALA Pets Anti-infective Drugs Sales by Country (2019 VS 2023 VS 2030) & (K Units)
Table 221. MEALA Pets Anti-infective Drugs Sales by Country (2019-2024) & (K Units)
Table 222. MEALA Pets Anti-infective Drugs Sales by Country (2025-2030) & (K Units)
Table 223. MEALA Pets Anti-infective Drugs Sales Price by Country (2019-2024) & (US$/Unit)
Table 224. MEALA Pets Anti-infective Drugs Sales Price by Country (2025-2030) & (US$/Unit)
Table 225. Mexico Pets Anti-infective Drugs Revenue (2019-2030) & (US$ Million)
Table 226. Brazil Pets Anti-infective Drugs Revenue (2019-2030) & (US$ Million)
Table 227. Israel Pets Anti-infective Drugs Revenue (2019-2030) & (US$ Million)
Table 228. Argentina Pets Anti-infective Drugs Revenue (2019-2030) & (US$ Million)
Table 229. Colombia Pets Anti-infective Drugs Revenue (2019-2030) & (US$ Million)
Table 230. Turkey Pets Anti-infective Drugs Revenue (2019-2030) & (US$ Million)
Table 231. Saudi Arabia Pets Anti-infective Drugs Revenue (2019-2030) & (US$ Million)
Table 232. UAE Pets Anti-infective Drugs Revenue (2019-2030) & (US$ Million)
Table 233. Key Raw Materials
Table 234. Raw Materials Key Suppliers
Table 235. Pets Anti-infective Drugs Distributors List
Table 236. Pets Anti-infective Drugs Customers List
Table 237. Research Programs/Design for This Report
Table 238. Authors List of This Report
Table 239. Secondary Sources
Table 240. Primary Sources
List of Figures
Figure 1. Pets Anti-infective Drugs Product Picture
Figure 2. Global Pets Anti-infective Drugs Market Size Growth Rate by Administration Method (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Pets Anti-infective Drugs Market Size Share 2019 VS 2023 VS 2030
Figure 4. External Use Picture
Figure 5. Internal Use Picture
Figure 6. Injection Picture
Figure 7. Global Pets Anti-infective Drugs Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 8. Global Pets Anti-infective Drugs Market Size Share 2019 VS 2023 VS 2030
Figure 9. Dog Picture
Figure 10. Cat Picture
Figure 11. Others Picture
Figure 12. Global Pets Anti-infective Drugs Revenue (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Pets Anti-infective Drugs Revenue (2019-2030) & (US$ Million)
Figure 14. Global Pets Anti-infective Drugs Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 15. Global Pets Anti-infective Drugs Revenue Market Share by Region: 2023 Versus 2030
Figure 16. Global Pets Anti-infective Drugs Revenue Market Share by Region (2019-2030)
Figure 17. Global Pets Anti-infective Drugs Sales (2019-2030) & (K Units)
Figure 18. Global Pets Anti-infective Drugs Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)
Figure 19. Global Pets Anti-infective Drugs Sales Market Share by Region (2019-2030)
Figure 20. US & Canada Pets Anti-infective Drugs Sales YoY (2019-2030) & (K Units)
Figure 21. Europe Pets Anti-infective Drugs Sales YoY (2019-2030) & (K Units)
Figure 22. China Pets Anti-infective Drugs Sales YoY (2019-2030) & (K Units)
Figure 23. Asia (Excluding China) Pets Anti-infective Drugs Sales YoY (2019-2030) & (K Units)
Figure 24. Middle East, Africa and Latin America (Excluding China) Pets Anti-infective Drugs Sales YoY (2019-2030) & (K Units)
Figure 25. Global Pets Anti-infective Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2023
Figure 26. Global Pets Anti-infective Drugs Manufacturers Sales Share Top 10 and Top 5 in 2023
Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 28. Global Pets Anti-infective Drugs Revenue by Administration Method (2019 VS 2023 VS 2030) & (US$ Million)
Figure 29. Global Pets Anti-infective Drugs Revenue Market Share by Type 2019 VS 2023 VS 2030
Figure 30. Global Pets Anti-infective Drugs Revenue Market Share by Administration Method (2019-2030)
Figure 31. Global Pets Anti-infective Drugs Sales by Administration Method (2019 VS 2023 VS 2030) & (K Units)
Figure 32. Global Pets Anti-infective Drugs Sales Market Share by Type 2019 VS 2023 VS 2030
Figure 33. Global Pets Anti-infective Drugs Sales Market Share by Administration Method (2019-2030)
Figure 34. Global Pets Anti-infective Drugs Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 35. Global Pets Anti-infective Drugs Revenue Market Share by Application 2019 VS 2023 VS 2030
Figure 36. Global Pets Anti-infective Drugs Revenue Market Share by Application (2019-2030)
Figure 37. Global Pets Anti-infective Drugs Sales by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 38. Global Pets Anti-infective Drugs Sales Market Share by Application 2019 VS 2023 VS 2030
Figure 39. Global Pets Anti-infective Drugs Sales Market Share by Application (2019-2030)
Figure 40. North America Pets Anti-infective Drugs Revenue Share by Administration Method (2019-2030)
Figure 41. North America Pets Anti-infective Drugs Sales Share by Administration Method (2019-2030)
Figure 42. North America Pets Anti-infective Drugs Revenue Share by Application (2019-2030)
Figure 43. North America Pets Anti-infective Drugs Sales Share by Application (2019-2030)
Figure 44. North America Pets Anti-infective Drugs Revenue Share by Country (2019-2030)
Figure 45. North America Pets Anti-infective Drugs Sales Share by Country (2019-2030)
Figure 46. Europe Pets Anti-infective Drugs Revenue Share by Administration Method (2019-2030)
Figure 47. Europe Pets Anti-infective Drugs Sales Share by Administration Method (2019-2030)
Figure 48. Europe Pets Anti-infective Drugs Revenue Share by Application (2019-2030)
Figure 49. Europe Pets Anti-infective Drugs Sales Share by Application (2019-2030)
Figure 50. Europe Pets Anti-infective Drugs Revenue Share by Country (2019-2030)
Figure 51. Europe Pets Anti-infective Drugs Sales Share by Country (2019-2030)
Figure 52. China Pets Anti-infective Drugs Revenue Share by Administration Method (2019-2030)
Figure 53. China Pets Anti-infective Drugs Sales Share by Administration Method (2019-2030)
Figure 54. China Pets Anti-infective Drugs Revenue Share by Application (2019-2030)
Figure 55. China Pets Anti-infective Drugs Sales Share by Application (2019-2030)
Figure 56. Asia Pets Anti-infective Drugs Revenue Share by Administration Method (2019-2030)
Figure 57. Asia Pets Anti-infective Drugs Sales Share by Administration Method (2019-2030)
Figure 58. Asia Pets Anti-infective Drugs Revenue Share by Application (2019-2030)
Figure 59. Asia Pets Anti-infective Drugs Sales Share by Application (2019-2030)
Figure 60. Asia Pets Anti-infective Drugs Revenue Share by Country (2019-2030)
Figure 61. Asia Pets Anti-infective Drugs Sales Share by Country (2019-2030)
Figure 62. MEALA Pets Anti-infective Drugs Revenue Share by Administration Method (2019-2030)
Figure 63. MEALA Pets Anti-infective Drugs Sales Share by Administration Method (2019-2030)
Figure 64. MEALA Pets Anti-infective Drugs Revenue Share by Application (2019-2030)
Figure 65. MEALA Pets Anti-infective Drugs Sales Share by Application (2019-2030)
Figure 66. MEALA Pets Anti-infective Drugs Revenue Share by Country (2019-2030)
Figure 67. MEALA Pets Anti-infective Drugs Sales Share by Country (2019-2030)
Figure 68. Pets Anti-infective Drugs Value Chain
Figure 69. Manufacturing Cost Structure
Figure 70. Pets Anti-infective Drugs Production Mode & Process
Figure 71. Direct Comparison with Distribution Share
Figure 72. Distributors Profiles
Figure 73. Years Considered
Figure 74. Research Process
Figure 75. Key Executives Interviewed
